Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1998 Jun;89(6):649–656. doi: 10.1111/j.1349-7006.1998.tb03267.x

Increased Hepatic Nicotinamide N‐Methyltransferase Activity as a Marker of Cancer Cachexia in Mice Bearing Colon 26 Adenocarcinoma

Atsushi Okamura 1, Yoshihisa Ohmura 1, Md Muzharul Islam 1, Masatoshi Tagawa 1,†, Keisuke Horitsu 2, Yoichi Moriyama 1, Shinji Fujimura 1,✉
PMCID: PMC5921875  PMID: 9703363

Abstract

When a cachexigenic subclone (clone 20) of murine colon 26 adenocarcinoma was transplanted into female BALB/c mice, hepatic NNMT activity continued to increase until death in proportion to progressive carcass weight loss, a marker of cancer cachexia. On the other hand, noncachexigenic subclone (clone 5)‐transplanted mice showed neither increase of NNMT activity nor carcass weight loss. Among cytostatic fluorinated pyrimidines, 5′‐dFUrd could inhibit the increase of NNMT activity and prevent weight loss in mice bearing clone 20. On the other hand, 2′‐dFUrd did not show these effects. 5‐FUra and Tegafur inhibited the increase of NNMT activity at higher concentrations. These findings suggest that the levels of hepatic NNMT activity are closely associated with the degree of weight loss, and they appear to be a useful marker of cancer cachexia.

Keywords: key words, Nicotinamide N‐methyltransferase, Cancer cachexia, Liver, Colon 26 adenocarcinoma

Full Text

The Full Text of this article is available as a PDF (175.5 KB).

REFERENCES

  • 1. ) D'Souza , J. , Caldwell , J. and Smith , R. L.Species variations in the N‐methylation and quaternization of [14C]pyridine . Xenobiotica , 10 , 151 – 157 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Seifert , R. , Hoshino , J. and Kröger , H.Nicotinamide methylation. Tissue distribution, developmental and neoplastic changes . Biochim. Biophys. Acta , 801 , 259 – 264 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Alton , T. A. and Abeles , R. H.Substrate specificity of nicotinamide methyltransferase isolated from porcine liver . Arch. Biochem. Biophys. , 260 , 601 – 608 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Aksoy , S. , Szumlanski , C. L. and Weinshilboum , R. M.Human liver nicotinamide N‐methyltransferase: cDNA cloning, expression and biochemical characterization . J. Biol. Chem. , 265 , 14835 – 14840 ( 1994. ). [PubMed] [Google Scholar]
  • 5. ) Aksoy , S. , Brandriff , B. F. , Ward , A. , Little , P. F. R. and Weinshilboum , R. M.Human nicotinamide N‐methyltransferase gene: molecular cloning, structural characterization and chromosomal localization . Genomics , 29 , 555 – 561 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Norton , J. A. , Peacock , J. L. and Morrison , S. D.Cancer cachexia . Crit. Rev. Oncol./Hematol. , 7 , 289 – 327 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) DeWys , W. D.Management of cancer cachexia . Semin. Oncol. , 12 , 452 – 460 ( 1985. ). [PubMed] [Google Scholar]
  • 8. ) Hanazawa , Y. , Kuroiwa , N. , Ogawa , M. , Moriyama , Y. and Fujimura , S.Characterization of nicotinamide methyltransferase in livers of mice bearing Ehrlich ascites tumors: preferential increase of activity . Tumor Biol. , 15 , 7 – 16 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Corbett , T. H. , Griswold , D. P. , Jr. , Roberts , B. J. , Peckham , J. C. and Schabel , F. M. , Jr.Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure . Cancer Res. , 35 , 2434 – 2439 ( 1975. ). [PubMed] [Google Scholar]
  • 10. ) Tanaka , Y. , Eda , H. , Tanaka , T. , Udagawa , T. , Ishikawa , T. , Horii , I. , Ishitsuka , H. , Kataoka , T. and Taguchi , T.Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma . Cancer Res. , 50 , 2290 – 2295 ( 1990. ). [PubMed] [Google Scholar]
  • 11. ) Strassmann , G. , Fong , M. , Kenney , J. S. and Jacob , C. O.Evidence for the involvement of interleukin 6 in experimental cancer cachexia . J. Clin. Invest. , 89 , 1681 – 1684 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Ouchi , K. F. , Tamura , S. , Mori , K. , Tanaka , Y. and Ishitsuka , H.Establishment and characterization of cachexia‐inducing and ‐non‐inducing clones of murine colon 26 carcinoma . Int. J. Cancer , 61 , 522 – 528 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Tanaka , Y. , Eda , H. , Fujimoto , K. , Tanaka , T. , Ishikawa , T. and Ishitsuka , H.Anticachectic activity of 5′‐deoxy‐5‐fluorouridine in a murine tumor cachexia model, colon 26 adenocarcinoma . Cancer Res. , 50 , 4528 – 4532 ( 1990. ). [PubMed] [Google Scholar]
  • 14. ) Nakagawa , K. , Miyazaki , M. , Okui , K. , Kato , N. , Moriyama , Y. and Fujimura , S.N1‐Methylnicotinamide level in the blood after nicotinamide loading as further evidence for malignant tumor burden . Jpn. J. Cancer Res. , 82 , 1277 – 1283 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Lowry , O. H. , Rosebrough , N. J. , Fair , A. L. and Randall , R. J.Protein measurement with the Folin phenol reagent . J. Biol. Chem. , 193 , 265 – 275 ( 1951. ). [PubMed] [Google Scholar]
  • 16. ) Chirgwin , J. M. , Przybyla , A. E. , MacDonald , R. J. and Rutter , W. J.Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease . Biochemistry , 18 , 5294 – 5299 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Yasumoto , K. , Mukaida , N. , Harada , A. , Kuno , K. , Akiyama , M. , Nakashima , E. , Fujioka , N. , Mai , M. , Kasahara , T. , Fujimoto‐Ouchi , K. , Mori , K. , Tanaka , Y. and Matsushima , K.Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma‐bearing mice . Cancer Res. , 55 , 921 – 927 ( 1995. ). [PubMed] [Google Scholar]
  • 18. ) Robbins , S. L.In“Pathological Basis of Disease,” pp. 106 – 115 ( 1974. ), W. B. Saunders Co. , Philadelphia . [Google Scholar]
  • 19. ) Nathanson , L. and Hall , T. C.A spectrum of tumors that produce paraneoplastic syndromes. Lung tumors: how they produce their syndromes . Ann. NY Acad. Sci. , 230 , 367 – 377 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) De Wys , W. D. , Begg , C. , Lavin , P. T. , Band , P. R. , Bennet , J. M. , Bertino , J. R. , Cohen , M. H. , Douglass , H. O. , Engstrom , P. F. , Ezdinli , E. Z. , Horton , J. , Johnson , G. J. , Moertel , C. G. , Oken , M. M. , Perlia , C. , Rosenbaum , C. , Silverstein , M. N. , Skeel , R. T. , Sponzo , R. W. and Tormey , D. C.Prognostic effect of weight loss prior to chemotherapy in cancer patients . Am. J. Med. , 69 , 491 – 497 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) De Wys , W. D. , Begg , C. , Band , P. and Tormey , D.The impact of malnutrition on treatment in breast cancer . Cancer Treat. Rep. , 65 ( Suppl. 5 ), 855 – 915 ( 1981. ). [PubMed] [Google Scholar]
  • 22. ) Warnold , I. , Lundholm , K. and Scherstein , T.Energy balance and body composition in cancer patients . Cancer Res. , 38 , 1801 – 1807 ( 1978. ). [PubMed] [Google Scholar]
  • 23. ) Mori , K. , Fujimoto‐Ouchi , K. , Ishikawa , T. , Sekiguchi , F. , Ishitsuka , H. and Tanaka , Y.Murine interleukin‐12 prevents the development of cancer cachexia in a murine model . Int. J. Cancer , 67 , 849 – 855 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Fujii , S. , Yuasa , A. , Kawachi , T. , Okamura , Y. , Wakasugi , H. and Yamamura , Y.Purification of toxohormone by carboxymethylcellulose column chromatography . Gann , 55 , 67 – 71 ( 1964. ). [PubMed] [Google Scholar]
  • 25. ) Masuno , H. , Yoshimura , H. , Ogawa , N. and Okuda , H.Isolation of a lipolytic factor (toxohormone‐L) from ascites fluid of patients with hepatoma and its effect on feeding behavior . Eur. J. Cancer Clin. Oncol. , 20 , 1177 – 1185 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Todorov , P. , Cariuk , P. , McDevitt , T. , Coles , B. , Fearon , K. and Tisdale , M.Characterization of a cancer cachectic factor . Nature , 379 , 739 – 742 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Kitada , S. , Hays , E. F. and Mead , J. F.Characterization of a lipid mobilizing factor from tumors . Prog. Lipid Res. , 20 , 823 – 826 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Taylor , D. D. , Gercel‐Taylor , C. , Jenio , L. G. and Devereux , D. F.Identification of a human tumor‐derived lipolysis‐promoting factor . Cancer Res. , 52 , 829 – 834 ( 1992. ). [PubMed] [Google Scholar]
  • 29. ) McDevitt , T. M. , Todorov , P. T. , Beck , S. A. , Khan , S. H. and Tisdale , M. J.Purification and characterization of a lipid‐mobilizing factor associated with cachexia‐inducing tumors in mice and humans . Cancer Res. , 55 , 1458 – 1463 ( 1995. ). [PubMed] [Google Scholar]
  • 30. ) Beutler , B. and Cerami , A.Cachectin and tumor necrosis factor as two sides of the same biological coin . Nature , 320 , 584 – 588 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Matthys , P. , Dijkmans , R. , Proost , P. , Van Damme , J. , Heremans , H. , Sobis , H. and Billiau , A.Severe cachexia in mice inoculated with interferon‐gamma‐producing tumor cells . Int. J. Cancer , 49 , 77 – 82 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Mori , M. , Yamaguchi , K. , Honda , S. , Nagasaki , K. , Ueda , M. , Abe , O. and Abe , K.Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia‐inhibitory factor . Cancer Res. , 51 , 6656 – 6659 ( 1991. ). [PubMed] [Google Scholar]
  • 33. ) Zugmaier , G. , Paiks , S. , Wilding , G. , Knabbe , C. , Bano , M. , Lupu , R. , Deschauner , B. , Simpson , S. , Dickson , R. B. and Lippmann , M.Transforming growth factor β induces cachexia and systemic fibrosis without an antitumor effect in nude mice . Cancer Res. , 51 , 3590 – 3594 ( 1991. ). [PubMed] [Google Scholar]
  • 34. ) Soda , K. , Kawakami , M. , Kashii , A. and Miyata , M.Characterization of mice bearing subclones of colon 26 adenocarcinoma disqualifies interleukin‐6 as the sole inducer of cachexia . Jpn. J. Cancer Res. , 85 , 1124 – 1130 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. ) Metcalf , D. , Nicola , N. A. and Gearing , D. P.Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice . Blood , 76 , 50 – 56 ( 1990. ). [PubMed] [Google Scholar]
  • 36. ) Socher , S. H. , Martinetz , D. , Craig , J. B. , Kuhn , J. K. and Oliff , A.Tumor necrosis factor not detectable in patients with clinical cancer cachexia . J. Natl. Cancer Inst. , 80 , 595 – 598 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 37. ) Fujimura , S. and Shimizu , M.Enhanced activity of tRNA‐pseudouridine synthetase in Yoshida ascites sarcoma . Biochem. Biophys. Res. Commun. , 79 , 763 – 768 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 38. ) Shimizu , M. and Fujimura , S.Studies on the abnormal excretion of pyrimidine nucleosides in the urine of Yoshida ascites sarcoma‐bearing rats. Increased excretion of deoxycytidine, pseudouridine and cytidine . Biochim. Biophys. Acta , 517 , 277 – 286 ( 1978. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Shimizu , M. and Fujimura , S.Origin of increased deoxycytidine excretion into urine of rats bearing Yoshida ascites sarcoma . Cancer Res. , 44 , 2387 – 2392 ( 1984. ). [PubMed] [Google Scholar]
  • 40. ) Asanagi , M. , Moriyama , Y. and Fujimura , S.Purification and characterization of thymidylate synthetase in liver of the mouse bearing Ehrlich ascites tumor . Arch. Biochem. Biophys. , 267 , 749 – 757 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Tanaka , N. , Sekiya , S. , Takamizawa , H. , Kato , N. , Moriyama , Y. and Fujimura , S.Characterization of a 54 kDa, αl‐antitrypsin‐like protein isolated from ascitic fluid of an endometrial cancer patient . Jpn. J. Cancer Res. , 82 , 1277 – 1283 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. ) Nakahara , W. and Fukuoka , F.Toxohormones: a characteristic toxic substance produced by cancer tissue . Gann , 40 , 45 – 69 ( 1949. ). [PubMed] [Google Scholar]
  • 43. ) Ishitsuka , H. , Miwa , M. , Takemoto , K. , Fukuoka , K. , Itoga , A. and Maruyama , H. B.Role of uridine phosphorylase for antitumor activity of 5′‐deoxy‐5‐fluorouridine . Gann , 71 , 112 – 123 ( 1980. ). [PubMed] [Google Scholar]
  • 44. ) Bollag , W. and Hartmann , H. R.Tumor inhibitory effects of a new fluorouracil derivative: 5′‐deoxy‐5‐fluorouridine . Eur. J. Cancer , 16 , 427 – 432 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 45. ) Eda , H. , Fujimoto , K. , Watanabe , S. , Ishikawa , T. , Ohiwa , T. , Tatsuno , K. , Tanaka , Y. and Ishitsuka , H.Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5′‐deoxy‐5‐fluorouridine . Jpn. J. Cancer Res. , 84 , 341 – 347 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Eda , H. , Fujimoto , K. , Watanabe , S. , Ura , M. , Hino , A. , Tanaka , Y. , Wada , K. and Ishitsuka , H.Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′‐deoxy‐5‐fluorouridine . Cancer Chemother. Pharmacol. , 32 , 333 – 338 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 47. ) Strassmann , G. , Masui , Y. , Chizzonite , R. and Fong , M.Mechanisms of experimental cancer cachexia. Local involvement of IL‐1 in colon‐26 tumor . J. Immunol. , 150 , 2341 – 2345 ( 1993. ). [PubMed] [Google Scholar]
  • 48. ) Fujimura , S. , Kato , N. , Han , J. Y. , Hanazawa , Y. , Nakagawa , K. and Horitsu , K.Increase of nicotinamide methyltransferase activity in the liver of the mouse after transplantation of Ehrlich ascites tumor . In“Advances in Tryptophan Research,” pp. 179 – 182 ( 1992. ). F. H. U. Press; , Japan . [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES